Tenax Therapeutics Inc (TENX)

[skyticket1]

Ladenburg Thalmann is a respected boutique investment house and their analyst report is officially published. Possibly you know better than certified and acknowledged analysts?!

The recently published meta-analysis about Levosimendan shows a completely different picture about market potential and efficacy. www.ncbi.nlm.nih.gov/pubmed/25652947 Possibly you know better than professors, doctors, anaesthesiologists,cardiologists and intensive care specialists?

Trade sale and merger prices can not be compared and certainly not weighed on future market potential of a product or technology in early stage, even phase 2. your rhetorical and cynical question is complete nonsense as you well know. Do you know the valuation of the first equity rounds of Facebook, Amgen, Biogen Idec, Actelion etc.? Opportunity and synergy, paired with timing and network, ability to sell and market, create those early stage deals and it is always a give and take negotiation and yes the 4.8 million are justified, but every entrepreneur would know that. Some prefer a smaller piece of the big cake, if that's what it takes to get the opportunity going.